IP Library Granted Patent US 7,504,530
Granted Patent B2
US 7,504,530 · App. 12/030,415 · Granted Mar 17, 2009

Methods for the preparation of fispemifene from ospemifene

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,504,530
App. No.
12/030,415
Granted
Mar 17, 2009
Kind
B2
Abstract

The present invention concerns a method for preparation of fispemifene by use of ospemifene as a starting material.

Claims (19)

1. A method for the preparation of a compound of formula (I) comprising:

wherein a compound of formula (II)

is alkylated with an alkylating reagent of the formula Hal-CH 2 —COOR, wherein Hal is halogen and R is a C 1 -C 4 alkyl, to give a compound of formula (III)

and the ester of formula (III) is reduced to give the compound of formula (I).

2. The method according to claim 1 , wherein Hal is 1, Br or Cl.

3. The method according to claim 2 , wherein Hal is Br.

4. The method according to claim 1 , wherein R is ethyl.

5. The method according to claim 1 , wherein the reduction of the compound (III) is carried out by lithium aluminium hydride.

6. The method according to any of the foregoing claims, wherein the compound (I) is the Z-isomer.

7. A compound of formula (III)

wherein R is a C 1-4 -alkyl.

8. The compound according to claim 7 wherein R is methyl, ethyl, or t-butyl.

9. The compound according to claim 7 wherein R is ethyl.

10. A method for making fispemifene comprising the step of reducing a compound according to formula (III)

wherein R is C 1 -C 4 alkyl, to make fispemifene.

11. The compound according to claim 10 wherein R is methyl, ethyl, or t-butyl.

12. The method according to claim 11 , wherein R is ethyl.

13. The method according to claim 11 , wherein the reduction of the compound (III) is carried out by lithium aluminium hydride.

14. The method according to any of the claims 10 - 13 , wherein the compound (I) is the Z-isomer.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Mar 11, 2013
From: HERCULES TECHNOLOGY GROWTH CAPITAL INC.
To: QUATRX PHARMACEUTICALS COMPANY
Reel/Frame 029963/0829 →
SECURITY AGREEMENT Recorded Apr 24, 2009
From: QUATRX PHARMACEUTICALS COMPANY
To: HERCULES TECHNOLOGY GROWTH CAPITAL, INC.
Reel/Frame 022584/0669 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 1, 2008
From: SODERVALL, MARJA; ELORANTA, MAIRE; KALAPUDAS, ARJA; KEARTON, BRIAN; MCKENZIE, MICHAEL
To: HORMOS MEDICAL LTD.
Reel/Frame 021177/0381 →